JW (Cayman) Therapeutics Co. Ltd

SEHK:2126 Stock Report

Market Cap: HK$912.4m

JW (Cayman) Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

JW (Cayman) Therapeutics has a total shareholder equity of CN¥1.7B and total debt of CN¥262.5M, which brings its debt-to-equity ratio to 15.6%. Its total assets and total liabilities are CN¥2.1B and CN¥462.3M respectively.

Key information

15.6%

Debt to equity ratio

CN¥262.50m

Debt

Interest coverage ration/a
CashCN¥1.01b
EquityCN¥1.68b
Total liabilitiesCN¥462.26m
Total assetsCN¥2.15b

Recent financial health updates

No updates

Recent updates

A Piece Of The Puzzle Missing From JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 34% Share Price Climb

May 10
A Piece Of The Puzzle Missing From JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 34% Share Price Climb

Calculating The Intrinsic Value Of JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

May 03
Calculating The Intrinsic Value Of JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?

Feb 03
JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?

Financial Position Analysis

Short Term Liabilities: 2126's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥264.5M).

Long Term Liabilities: 2126's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥197.8M).


Debt to Equity History and Analysis

Debt Level: 2126 has more cash than its total debt.

Reducing Debt: 2126 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 2126 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 2126 has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 13.6% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.